advertisement
Etminan M 9
Showing records 1 to 9 | Display all abstracts from Etminan M106409 Risk of Intraocular Pressure Increase With Intravitreal Injections of Vascular Endothelial Growth Factor Inhibitors: A Cohort Study
Spini A
American Journal of Ophthalmology 2022; 248: 45-50
106029 Impact of the use of anti-glaucoma medications on the risk of herpetic keratitis recurrence
He B; Tavakoli H
International Ophthalmology 2023; 43: 1559-1564
106409 Risk of Intraocular Pressure Increase With Intravitreal Injections of Vascular Endothelial Growth Factor Inhibitors: A Cohort Study
Giometto S; Donnini S
American Journal of Ophthalmology 2022; 248: 45-50
106029 Impact of the use of anti-glaucoma medications on the risk of herpetic keratitis recurrence
Etminan M
International Ophthalmology 2023; 43: 1559-1564
106409 Risk of Intraocular Pressure Increase With Intravitreal Injections of Vascular Endothelial Growth Factor Inhibitors: A Cohort Study
Posarelli M
American Journal of Ophthalmology 2022; 248: 45-50
106029 Impact of the use of anti-glaucoma medications on the risk of herpetic keratitis recurrence
Shokoohi S; Iovieno A
International Ophthalmology 2023; 43: 1559-1564
106409 Risk of Intraocular Pressure Increase With Intravitreal Injections of Vascular Endothelial Growth Factor Inhibitors: A Cohort Study
Dotta F
American Journal of Ophthalmology 2022; 248: 45-50
106029 Impact of the use of anti-glaucoma medications on the risk of herpetic keratitis recurrence
Yeung SN
International Ophthalmology 2023; 43: 1559-1564
106409 Risk of Intraocular Pressure Increase With Intravitreal Injections of Vascular Endothelial Growth Factor Inhibitors: A Cohort Study
Ziche M; Tosi GM; Girardi A; Lucenteforte E; Gini R; Etminan M; Virgili G
American Journal of Ophthalmology 2022; 248: 45-50
